Annual Cash & Cash Equivalents
$104.81 M
-$134.03 M-56.12%
December 31, 2023
Summary
- As of February 10, 2025, AXNX annual cash & cash equivalents is $104.81 million, with the most recent change of -$134.03 million (-56.12%) on December 31, 2023.
- During the last 3 years, AXNX annual cash & cash equivalents has fallen by -$136.37 million (-56.54%).
Performance
AXNX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$239.45 M
+$70.83 M+42.01%
September 30, 2024
Summary
- As of February 10, 2025, AXNX quarterly cash and cash equivalents is $239.45 million, with the most recent change of +$70.83 million (+42.01%) on September 30, 2024.
- Over the past year, AXNX quarterly cash and cash equivalents has increased by +$92.13 million (+62.54%).
Performance
AXNX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AXNX Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -56.1% | +62.5% |
3 y3 years | -56.5% | +4.7% |
5 y5 years | +6.6% | +40.0% |
AXNX Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -56.1% | at low | -0.8% | -56.2% |
5 y | 5-year | -56.5% | at low | -16.8% | -56.2% |
alltime | all time | -56.5% | -92.2% | -16.8% | -91.6% |
Axonics Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $239.45 M(+42.0%) |
Jun 2024 | - | $168.62 M(-27.5%) |
Mar 2024 | - | $232.65 M(+122.0%) |
Dec 2023 | $104.81 M(-56.1%) | $104.81 M(-28.9%) |
Sep 2023 | - | $147.32 M(+1.4%) |
Jun 2023 | - | $145.34 M(-39.5%) |
Mar 2023 | - | $240.10 M(+0.5%) |
Dec 2022 | $238.85 M(+8.1%) | $238.85 M(-1.0%) |
Sep 2022 | - | $241.33 M(+18.7%) |
Jun 2022 | - | $203.24 M(-4.7%) |
Mar 2022 | - | $213.18 M(-3.5%) |
Dec 2021 | $220.88 M | $220.88 M(-3.5%) |
Sep 2021 | - | $228.80 M(-1.0%) |
Jun 2021 | - | $231.14 M(+76.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $130.96 M(-45.7%) |
Dec 2020 | $241.18 M(+41.0%) | $241.18 M(-10.4%) |
Sep 2020 | - | $269.28 M(-6.4%) |
Jun 2020 | - | $287.68 M(+80.0%) |
Mar 2020 | - | $159.82 M(-6.6%) |
Dec 2019 | $171.08 M(+74.0%) | $171.08 M(+124.4%) |
Sep 2019 | - | $76.23 M(-7.8%) |
Jun 2019 | - | $82.68 M(-7.4%) |
Mar 2019 | - | $89.33 M(-9.1%) |
Dec 2018 | $98.31 M(+302.9%) | $98.31 M(+387.9%) |
Sep 2018 | - | $20.15 M(-18.5%) |
Jun 2018 | - | $24.73 M(+1.4%) |
Dec 2017 | $24.40 M(+197.2%) | $24.40 M |
Dec 2016 | $8.21 M | - |
FAQ
- What is Axonics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Axonics?
- What is Axonics annual cash & cash equivalents year-on-year change?
- What is Axonics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Axonics?
- What is Axonics quarterly cash and cash equivalents year-on-year change?
What is Axonics annual cash & cash equivalents?
The current annual cash & cash equivalents of AXNX is $104.81 M
What is the all time high annual cash & cash equivalents for Axonics?
Axonics all-time high annual cash & cash equivalents is $241.18 M
What is Axonics annual cash & cash equivalents year-on-year change?
Over the past year, AXNX annual cash & cash equivalents has changed by -$134.03 M (-56.12%)
What is Axonics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AXNX is $239.45 M
What is the all time high quarterly cash and cash equivalents for Axonics?
Axonics all-time high quarterly cash and cash equivalents is $287.68 M
What is Axonics quarterly cash and cash equivalents year-on-year change?
Over the past year, AXNX quarterly cash and cash equivalents has changed by +$92.13 M (+62.54%)